Antiplatelet agents are one of the main interventions for recurrent ischemic stroke prevention. Their time of use, dosage, and combination of therapy have different effects in terms of stroke risk reduction and adverse effects. This review provides an evidence-based update of the latest on antiplatelet therapy for stroke prevention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ncl.2013.03.004 | DOI Listing |
Publication Analysis
Top Keywords
stroke prevention
12
platelet antiaggregants
4
stroke
4
antiaggregants stroke
4
prevention antiplatelet
4
antiplatelet agents
4
agents main
4
main interventions
4
interventions recurrent
4
recurrent ischemic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!